Comprehensive guide to Biosimilar Drug Regulation cases, courts, and legal analysis.
Johnson & Johnson v. Samsung Bioepis Co Ltd, decided by Third Circuit on April 14, 2026, resulted in a defendant win outcome. The Third Circuit affirmed the District Court's grant of summary judgment ...
Amgen Inc v. Celltrion USA Inc, decided by Third Circuit on June 5, 2025, resulted in a mixed outcome. The Third Circuit affirmed the District Court's finding of infringement of Amgen's patents for it...
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on March 14, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Mylan's proposed ...
AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.